S Wolf, VJ Balciuniene, G Laganovska, U Menchini… - Ophthalmology, 2014 - Elsevier
Objective To compare the efficacy and safety of ranibizumab 0.5 mg, guided by visual acuity
(VA) stabilization or disease activity criteria, versus verteporfin photodynamic therapy (vPDT) …